Practical Guide to EU Funding for Research, Development & Innovation

The EU supports research and innovation activities through a range of programmes, including the Seventh Framework Programme for Research (FP7), the Competitiveness and Innovation Programme (CIP) and Structural Funds. Now the European Commission is developing a guide to help researchers select the right programme for their activities and even combine funds from different sources. A draft version of the guide is now ready and the Commission is keen to receive feedback on the document from the research community.

At the heart of the guide is a six-point checklist designed to help researchers identify the most relevant funding source for their needs. Questions cover the eligibility of the organisation or company, the eligibility of the planned activity, the timeframe for the project, the type of financial support needed and the identity of any other partners involved.

With a budget of over €50 billion for the period 2007 to 2013, FP7 is the EU's main instrument for the support of research and development activities. Meanwhile the €3.6 billion CIP initiative aims to boost the competitiveness of European businesses, with a focus on eco-innovation, information and communication technologies (ICTs) and renewable energies and energy efficiency.

Structural Funds are designed to reduce disparities in the level of development among regions and Member States. Although the amount of funding allocated to research and innovation varies from region to region, it is estimated that the total amount allocated to these activities will top the €99 billion mark for the period 2007 to 2013.

The guide explains how funds from these three sources can be combined to best effect, without falling foul of co-financing rules (which require recipients of most EU funds to finance part of their project from non-EU sources). The trick, according to the guide, is to use complementary financing.

"For example, separate but related activities or parts of a project can be funded by the Structural Funds, FP7 or the CIP," the guide reads. "Equally, the different funding sources may support different phases of the development of a technology over time, starting from basic research, to applied research, to demonstration or to pre-competitive market introduction."

A series of examples illustrates how different organisations might draw on different funds for different activities or phases of their projects.

The guide also notes that now is a good time to combine funds from these three sources. They share a common timeframe (2007 to 2013), and thanks to the Lisbon Strategy, research and innovation are now seen as crucial for regional development, a fact which is reflected in the Structural Funds. At the same time, the role of the regions in research is taken into account in both FP7 and CIP.

The Commission is keen to receive comments and suggestions by the end of April on how the guide can be made even more practical and user-friendly. Once finalised, the online version of the guide will be updated regularly and will also include links to the relevant national and regional programmes.

For further information, and a copy of the draft Practical Guide, please visit:
http://cordis.europa.eu/eu-funding-guide/home_en.html

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...